"Biomedical Technology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The application of technology to the solution of medical problems.
Descriptor ID |
D020811
|
MeSH Number(s) |
J01.897.115
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Biomedical Technology".
Below are MeSH descriptors whose meaning is more specific than "Biomedical Technology".
This graph shows the total number of publications written about "Biomedical Technology" by people in this website by year, and whether "Biomedical Technology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2021 | 1 | 1 | 2 |
2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomedical Technology" by people in Profiles.
-
The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa. Value Health Reg Issues. 2023 Mar; 34:23-30.
-
Introducing an Ethics Framework for health priority-setting in South Africa on the path to universal health coverage. S Afr Med J. 2022 03 02; 112(3):240-244.
-
Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates. Pharmacoeconomics. 2022 01; 40(1):31-43.
-
Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders. AIDS. 2021 01 01; 35(1):15-22.
-
Advances in patented interpenetrating polymeric networks for biomedical applications. Pharm Pat Anal. 2018 May 01; 7(3):99-101.
-
Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness". Int J Health Policy Manag. 2017 04 01; 6(4):233-236.
-
Digital technology, population health, and health equity. J Public Health Policy. 2016 Nov; 37(Suppl 2):145-153.